Oura has launched Oura Ring 5 – 40% smaller than its predecessor – alongside a major software expansion that moves the platform beyond tracking into proactive health monitoring, metabolic insights, and connected clinical care.
The hardware redesign delivers the world’s smallest smart ring with 12 signal pathways engineered for greater accuracy across more finger types and skin tones, week-long battery life, and a new portable charging case.
The software updates are where the strategic expansion is most visible. Health Radar introduces continuous background monitoring of blood pressure signals and nighttime breathing patterns, surfacing early cardiovascular warning signs before they become problems. GLP-1 Insights brings medication dosing, side effect tracking, weight tracking, and biometric data into a single longitudinal view for the growing population on GLP-1 therapies. And Health Records allows U.S. members to import diagnosed conditions, medications, lab results, and allergies directly into the app – building on the Galen AI acquisition from earlier this month and fulfilling Oura’s CMS Health Technology Ecosystem pledge.
For women’s health specifically, the previously announced Menopause Insights (with the proprietary Menopause Impact Scale) and Hormonal Birth Control support in Cycle Insights are now live globally. Lab Uploads launching June 30 will let members place blood biomarkers alongside cycle and biometric data.
Oura is also partnering with Counsel Health to bring AI-enabled medical care directly into the app (available in 43 U.S. states), and with ResMed for sleep disorder referrals when nighttime breathing disturbances are detected.
The Ring 5 launchmarks an already extraordinary year for Oura: the women’s health AI model, Galen AI acquisition, hormonal health features, Natural Cycles partnership, Withings-style cardiovascular data, confidential IPO filing, and now a hardware refresh with blood pressure monitoring and health records. The cumulative picture is a company building a comprehensive health platform with women’s health as a central pillar – heading into a public offering.
